SUPRIYA

Supriya Lifescience Share Price

₹703.50 -5.95 (-0.84%)

16 May, 2025 10:55

SIP TrendupStart SIP in SUPRIYA

Start SIP

Performance

  • Low
  • ₹691
  • High
  • ₹713
  • 52 Week Low
  • ₹330
  • 52 Week High
  • ₹842
  • Open Price₹709
  • Previous Close₹709
  • Volume104,923

Investment Returns

  • Over 1 Month -4.02%
  • Over 3 Month + 5.51%
  • Over 6 Month + 9.17%
  • Over 1 Year + 85.69%
SIP Lightning

Smart Investing Starts Here Start SIP with Supriya Lifescience for Steady Growth!

Invest Now

Supriya Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 32.4
  • PEG Ratio
  • 0.7
  • Market Cap Cr
  • 5,662
  • P/B Ratio
  • 6.3
  • Average True Range
  • 34.45
  • EPS
  • 21.68
  • Dividend Yield
  • 0.1
  • MACD Signal
  • -10.92
  • RSI
  • 56.57
  • MFI
  • 46.7

Supriya Lifescience Financials

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹703.50
-5.95 (-0.84%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹674.86
  • 50 Day
  • ₹682.18
  • 100 Day
  • ₹675.34
  • 200 Day
  • ₹626.62

Resistance and Support

702.25 Pivot Speed
  • R3 746.80
  • R2 729.55
  • R1 719.50
  • S1 692.20
  • S2 674.95
  • S3 664.90

What's your outlook on Supriya Lifescience?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) with over 38 APIs across various therapeutic segments. It exports to 86 countries, supplying high-quality APIs for pharmaceuticals, nutraceuticals, and personal care industries.

Supriya Lifescience has an operating revenue of Rs. 670.56 Cr. on a trailing 12-month basis. An annual revenue growth of 24% is outstanding, Pre-tax margin of 29% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 89 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 123 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Supriya Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-03-10 Others Inter-alia, to consider 1. Appointment of Company Secretary and Compliance Officer of the Company. 2. Other business matters. per share(30%)Final Dividend
2025-01-24 Quarterly Results & Others To consider other business matters. per share(30%)Final Dividend
2024-10-28 Quarterly Results
2024-08-10 Quarterly Results
2024-05-28 Audited Results & Final Dividend

Supriya Lifescience F&O

Supriya Lifescience Shareholding Pattern

68.3%
0.66%
1.7%
7.19%
16.4%
5.75%

About Supriya Lifescience

  • NSE Symbol
  • SUPRIYA
  • BSE Symbol
  • 543434
  • ISIN
  • INE07RO01027

Similar Stocks to Supriya Lifescience

Supriya Lifescience FAQs

Supriya Lifescience share price is ₹703 As on 16 May, 2025 | 10:41

The Market Cap of Supriya Lifescience is ₹5662 Cr As on 16 May, 2025 | 10:41

The P/E ratio of Supriya Lifescience is 32.4 As on 16 May, 2025 | 10:41

The PB ratio of Supriya Lifescience is 6.3 As on 16 May, 2025 | 10:41

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23